Candano, Freddie V.
HRN: 16-02-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
CEFTRIAXONE 1G (VIAL)
12/09/2025
12/16/2025
IV
2g
Od
Non Healing Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes